Abbreviations: (CGM) continuous glucose monitoring; (E&M) evaluation and monitoring
Introduction
Cont inuous glucose monitoring (CGM) technology offers tremendous potential for helping clinicians and patients improve glycemic control. However, unless clinicians are adequately reimbursed for their time and expertise, CGM technology will not be used. Clinicians must be paid for the services they provide. This presentation briefly reviews some of the obstacles to using CGM technology and then discusses strategies for using Evaluation and Monitoring (E&M) coding to optimize reimbursement.
Challenges to Using CGM Technology
Several factors make the use of CGM technology challenging for physicians, including physician time for patient evaluation, training, and education. Equipment purchases are also time consuming and expensive. However, the greatest challenge is obtaining reimbursement.
In December 2003, the Blue Cross Blue Shield Technology Evaluation Center stated that CGM does not meet their criteria and is thus considered an experimental or investigational tool. As a result, many other plans have chosen not to reimburse for CGM. Today, plans in fewer than half of the states provide coverage for CGM.
Two Paths of CGM
Current CGM technology seems to be heading in two directions. Some systems take a physician-centered approach whereas other systems are much more patientcentered. For example patients using the Medtronic CGMS Gold device wear it for three days but cannot see the data until they return to the physician for data download and interpretation. In contrast, patient-centered CGM systems provide real-time data to patients, who can then act upon changes in glucose as they occur.
Physician-Centered
A number of steps are involved in getting patients started on a physician-centered CGM system. The first steps include equipment purchase and staff training. Next, the patient must be evaluated to see whether CGM is, in fact, needed. If so, prior authorization may then be required. After that, staff must spend time attaching and calibrating the device as well as training the patient to use the device. In our office pump patients are asked to come back for an interval visit the day after attachment so that we can download data and make any necessary therapy changes. The patient then returns for a second follow-up visit during which data from the full three days are downloaded and interpreted. The final therapy adjustments are then made. Table 1 presents a schematic of the various codes that may be used to bill for these services and their estimated reimbursement values.
Patient-Centered
As with the physician-centered approach, use of patientcentered CGM systems requires patient evaluation, staff training, patient training, and follow-up. However, because patients will receive and act upon real-time data, thorough patient education in interpreting data must also be provided. It is important to remember that actual reimbursement for services is often quite different than what is billed. For example, reimbursement for code 99215 is set at $230.00; however, the average reimbursement for this code in our office is approximately $100.00.
Documentation
Complete documentation is required to justify billing for services associated with CGM use. Figure 1 provides sample wording that can be used to document the need for CGM as assessed at the initial visit (in addition to standard E&M documentation). 1
Figure 1. CGM Documentation: Initial Visit

"This patient's blood glucose is not in control.
Conventional data is inadequate to appropriately adjust therapy. CGM was ordered. The indications and possible complications of CGM were explained fully to the patient"
When documenting the procedure used to place the CGM device, it is helpful to provide step-by-step descriptions so that the individuals responsible for reviewing these reports can better understand the complexity of all that is involved. Figure 2 provides sample wording to describe the procedure. The CGM was calibrated using finger stick blood glucose. The patient was released, and then returned in 1 hour to ensure proper function of the device. The patient was instructed on the insulin/glucose log and is to return in 1 day for interim download and in 72 hours for removal of the device."
Documentation is also required for the interval and follow-up visits. Figure 3 provides sample wording for the interval visit. Figure 4 presents a list of common findings from CGM downloads. It is helpful to include printed graphs from the downloaded data to provide additional explanation of the interpretation. 
